Aster Hospital Mankhool pioneers next-generation heart imaging in Gulf
The first patient treated using the technology was a 52-year-old Dubai resident with type 2 diabetes, hypertension and high cholesterol who presented with worsening chest pain and was diagnosed with Acute Coronary Syndrome (ACS-NSTEMI)
22 July, 2026
TT
16
Aster Hospital Mankhool has become the first hospital in the Gulf region to successfully use the Cornaris P80/P80-E Optical Coherence Tomography (OCT) platform developed by Vivolight during a complex coronary intervention, marking a milestone in the adoption of advanced cardiovascular imaging technologies in the region.
The hospital, ranked fourth in the UAE in Newsweek’s World’s Best Hospitals 2026 list, said the next-generation imaging platform provides clinicians with high-resolution, real-time images from inside coronary arteries, enabling more precise diagnosis and treatment of complex coronary artery disease.
Unlike conventional angiography, which relies on X-ray images to outline blood vessels, the OCT platform uses near-infrared light to generate detailed cross-sectional images of artery walls. The technology enables clinicians to assess the location, composition and severity of arterial blockages, calcium build-up and blood flow within a single imaging procedure.
Dr Naveed Ahmed, head of Cardiac Services, Aster Hospitals & Clinics, UAE, said: “This technology allows us to see the heart artery in a completely new way. Instead of relying only on traditional images, we can now understand the structure and composition of the blockage, assess the surrounding artery environment in greater detail, and perform functional assessment of the treated vessel. This enables greater precision during complex procedures and helps us make more informed clinical decisions to achieve better patient outcomes.
“Using OCT imaging, we were able to obtain a detailed internal assessment of the artery, guiding precise treatment using a drug-eluting stent, a drug-coated balloon and treatment of the additional distal lesion. The procedure successfully restored normal blood flow. The patient underwent treatment on June 2, 2026, was discharged the following day in stable condition, and has remained symptom-free since the intervention. This level of precision allows us to optimise every stage of treatment and deliver the best possible care for patients.”
The first patient treated using the technology was a 52-year-old Dubai resident with type 2 diabetes, hypertension and high cholesterol who presented with worsening chest pain and was diagnosed with Acute Coronary Syndrome (ACS-NSTEMI). Further assessment identified a complex blockage involving the left anterior descending (LAD) artery and an additional lesion in the distal artery.
The technology was used during a Percutaneous Coronary Intervention (PCI), a minimally invasive procedure that treats blocked coronary arteries using balloons and stents without the need for open-heart surgery.
Dr Sherbaz Bichu, CEO – Aster Hospitals & Clinics, UAE, Oman & Bahrain, said: “At Aster Hospital, we are proud to be the first in the Gulf to introduce this next-generation heart imaging technology. Our patients deserve access to advanced diagnostic tools that enable our clinical teams to make more precise and informed treatment decisions.
“Optical Coherence Tomography allows our cardiac specialists to capture detailed artery scans within seconds, strengthening our ability to manage complex cardiac cases with greater accuracy and improve patient outcomes. This milestone reflects our continued commitment to bringing globally validated innovations into patient care and advancing cardiovascular excellence across the region.”
The Cornaris P80/P80-E platform offers multiple imaging modes, including Full View Mode, which scans up to 80mm of an artery in two seconds, High-Definition Mode, which captures 55mm in 2.75 seconds, and Super-Fast Mode, capable of scanning 40mm in one second.
According to Aster, the imaging system is currently used in more than 300 hospitals in China and has expanded into international markets including the United States, Indonesia, Chile, Armenia, Hong Kong and Macao.
The hospital also cited published clinical research indicating that OCT-guided coronary interventions can improve outcomes compared with conventional angiography-guided procedures, with studies reporting reductions in cardiac mortality of 39–46 per cent and stent-related complications of 48–64 per cent.
The milestone comes as cardiovascular disease remains one of the region’s leading health challenges, accounting for approximately 40 per cent of deaths in the UAE and 33–38 per cent across the GCC, underscoring the growing focus on advanced diagnostic technologies to improve patient outcomes.





















